Cargando…

Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India

RATIONALE: Vancomycin remains the standard of care for gram-positive bacterial infections, though there are significant developments in newer antibacterial agents. Efficacy can be improved by linking pharmacokinetic with pharmacodynamic principles, thus leading to optimum antibiotic exposure. There...

Descripción completa

Detalles Bibliográficos
Autores principales: Mali, Nitin B, Deshpande, Siddharth P, Wandalkar, Poorwa P, Gupta, Vishal A, Karnik, Niteen D, Gogtay, Nithya J, Nataraj, Gita, Mehta, Preeti R, Thatte, Urmila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900894/
https://www.ncbi.nlm.nih.gov/pubmed/31911742
http://dx.doi.org/10.5005/jp-journals-10071-23289
_version_ 1783477417580429312
author Mali, Nitin B
Deshpande, Siddharth P
Wandalkar, Poorwa P
Gupta, Vishal A
Karnik, Niteen D
Gogtay, Nithya J
Nataraj, Gita
Mehta, Preeti R
Thatte, Urmila
author_facet Mali, Nitin B
Deshpande, Siddharth P
Wandalkar, Poorwa P
Gupta, Vishal A
Karnik, Niteen D
Gogtay, Nithya J
Nataraj, Gita
Mehta, Preeti R
Thatte, Urmila
author_sort Mali, Nitin B
collection PubMed
description RATIONALE: Vancomycin remains the standard of care for gram-positive bacterial infections, though there are significant developments in newer antibacterial agents. Efficacy can be improved by linking pharmacokinetic with pharmacodynamic principles, thus leading to optimum antibiotic exposure. There is scarcity of pharmacokinetic data in Indian intensive care unit (ICU) population. MATERIALS AND METHODS: Fifteen subjects with suspected or proven gram-positive bacterial infection of either gender between 18 years and 65 years of age were enrolled. Vancomycin at the dose of 1 g every 12 hours was administered over 1-hour period and pharmacokinetic assessments performed on blood samples collected on days 1 and 3. Vancomycin concentrations were measured on validated liquid chromatography mass spectrometry method. Pharmacokinetic parameters were calculated using Winnonlin (Version 6.3; Pharsight, St. Louis, MO). RESULTS: The mean C(max,) elimination half-life, AUC(0–12hours), volume of distribution, and clearance of single dose were 36.46 μg/mL (±14.87), 3.98 hours (±1.31), 113.51 μg/mL (±49.51), 52.01 L (±31.31), and 8.90 mL/minute (±3.29), respectively, and at steady state were 40.87 μg/mL (±19.29), 6.27 hours (±3.39), 147.94 μg/mL (±72.89), 56.39 L (±42.13), and 6.98 mL/minute (±4.48), respectively. The elimination half-life increased almost two-fold at steady state. The steady state mean AUC(0–24) was 295.89 µg/mL (±153.82). Out of 45 trough levels, 32 (71.11%) concentrations were below recommended range. CONCLUSION: Recommended AUC(0–24hours) and trough concentrations were not achieved in majority of patients with current dosing, suggesting reevaluation of current vancomycin dosing. Individualized treatment based on close monitoring of vancomycin serum concentrations in critically ill patients is imperative. HOW TO CITE THIS ARTICLE: Mali NB, Deshpande SP, Wandalkar PP, Gupta VA, Karnik ND, Gogtay NJ, et al. Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India. IJCCM 2019;23(11):513–517.
format Online
Article
Text
id pubmed-6900894
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-69008942020-01-07 Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India Mali, Nitin B Deshpande, Siddharth P Wandalkar, Poorwa P Gupta, Vishal A Karnik, Niteen D Gogtay, Nithya J Nataraj, Gita Mehta, Preeti R Thatte, Urmila Indian J Crit Care Med Original Article RATIONALE: Vancomycin remains the standard of care for gram-positive bacterial infections, though there are significant developments in newer antibacterial agents. Efficacy can be improved by linking pharmacokinetic with pharmacodynamic principles, thus leading to optimum antibiotic exposure. There is scarcity of pharmacokinetic data in Indian intensive care unit (ICU) population. MATERIALS AND METHODS: Fifteen subjects with suspected or proven gram-positive bacterial infection of either gender between 18 years and 65 years of age were enrolled. Vancomycin at the dose of 1 g every 12 hours was administered over 1-hour period and pharmacokinetic assessments performed on blood samples collected on days 1 and 3. Vancomycin concentrations were measured on validated liquid chromatography mass spectrometry method. Pharmacokinetic parameters were calculated using Winnonlin (Version 6.3; Pharsight, St. Louis, MO). RESULTS: The mean C(max,) elimination half-life, AUC(0–12hours), volume of distribution, and clearance of single dose were 36.46 μg/mL (±14.87), 3.98 hours (±1.31), 113.51 μg/mL (±49.51), 52.01 L (±31.31), and 8.90 mL/minute (±3.29), respectively, and at steady state were 40.87 μg/mL (±19.29), 6.27 hours (±3.39), 147.94 μg/mL (±72.89), 56.39 L (±42.13), and 6.98 mL/minute (±4.48), respectively. The elimination half-life increased almost two-fold at steady state. The steady state mean AUC(0–24) was 295.89 µg/mL (±153.82). Out of 45 trough levels, 32 (71.11%) concentrations were below recommended range. CONCLUSION: Recommended AUC(0–24hours) and trough concentrations were not achieved in majority of patients with current dosing, suggesting reevaluation of current vancomycin dosing. Individualized treatment based on close monitoring of vancomycin serum concentrations in critically ill patients is imperative. HOW TO CITE THIS ARTICLE: Mali NB, Deshpande SP, Wandalkar PP, Gupta VA, Karnik ND, Gogtay NJ, et al. Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India. IJCCM 2019;23(11):513–517. Jaypee Brothers Medical Publishers 2019-11 /pmc/articles/PMC6900894/ /pubmed/31911742 http://dx.doi.org/10.5005/jp-journals-10071-23289 Text en Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd. © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Article
Mali, Nitin B
Deshpande, Siddharth P
Wandalkar, Poorwa P
Gupta, Vishal A
Karnik, Niteen D
Gogtay, Nithya J
Nataraj, Gita
Mehta, Preeti R
Thatte, Urmila
Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India
title Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India
title_full Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India
title_fullStr Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India
title_full_unstemmed Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India
title_short Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India
title_sort single-dose and steady-state pharmacokinetics of vancomycin in critically ill patients admitted to medical intensive care unit of india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900894/
https://www.ncbi.nlm.nih.gov/pubmed/31911742
http://dx.doi.org/10.5005/jp-journals-10071-23289
work_keys_str_mv AT malinitinb singledoseandsteadystatepharmacokineticsofvancomycinincriticallyillpatientsadmittedtomedicalintensivecareunitofindia
AT deshpandesiddharthp singledoseandsteadystatepharmacokineticsofvancomycinincriticallyillpatientsadmittedtomedicalintensivecareunitofindia
AT wandalkarpoorwap singledoseandsteadystatepharmacokineticsofvancomycinincriticallyillpatientsadmittedtomedicalintensivecareunitofindia
AT guptavishala singledoseandsteadystatepharmacokineticsofvancomycinincriticallyillpatientsadmittedtomedicalintensivecareunitofindia
AT karnikniteend singledoseandsteadystatepharmacokineticsofvancomycinincriticallyillpatientsadmittedtomedicalintensivecareunitofindia
AT gogtaynithyaj singledoseandsteadystatepharmacokineticsofvancomycinincriticallyillpatientsadmittedtomedicalintensivecareunitofindia
AT natarajgita singledoseandsteadystatepharmacokineticsofvancomycinincriticallyillpatientsadmittedtomedicalintensivecareunitofindia
AT mehtapreetir singledoseandsteadystatepharmacokineticsofvancomycinincriticallyillpatientsadmittedtomedicalintensivecareunitofindia
AT thatteurmila singledoseandsteadystatepharmacokineticsofvancomycinincriticallyillpatientsadmittedtomedicalintensivecareunitofindia